Showing results (381-390 of 545) with videos related to
Sort By:
Pageof 55
Plos One|July 23, 2013
Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapyAnna Maria Geretti, Zoe Fox, Jeffrey A Johnson, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 15, 2005
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive PatientsAntonella d'arminio Monforte, Alessandro Cozzi-Lepri, Andrew Phillips, et al.Antiviral Therapy|June 25, 2008
Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological responseKoen Deforche, Alessandro Cozzi-Lepri, Kristof Theys, et al.Nanoscale|July 10, 2013
Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cellsLine Hansen, Esben Kjær Unmack Larsen, Erik Holm Nielsen, et al.Toxicology and Applied Pharmacology|November 13, 2012
Superparamagnetic iron oxide polyacrylic acid coated γ-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy miceNina K Iversen, Sebastian Frische, Karen Thomsen, et al.Magnetic Resonance in Medicine|July 17, 2025
Measurement of renal cortex perfusion: A direct comparison of arterial spin labelling magnetic resonance imaging and [15O]H2O positron emission tomographyNaja Enevold Olsen, Christian Østergaard Mariager, Maibritt Meldgaard Arildsen, et al.AIDS (London, England)|May 12, 2017
Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individualsLene Ryom, Amanda Mocroft, Ole Kirk, et al.Clinical Trials (London, England)|May 2, 2012
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) studyAbdel G Babiker, Sean Emery, Gerd Fätkenheuer, et al.Plos One|May 30, 2014
Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmissionAlison J Rodger, Andrew Phillips, Andrew Speakman, et al.Plos One|October 29, 2024
How can HIV self-testing facilitate increased access to HIV testing among multiply marginalised populations? Perspectives from GBMSM and trans women in England and WalesIsaac Yen-Hao Chu, Fiona M Burns, Talen Wright, et al.Pageof 55